Last 12 months
Inside the activity.
9 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2024 Filed May 3, 2024 21:24 UTC |
Fyrwald J ErikDirector · CEO
|
GrantRestricted Stock Units · Derivative | 47,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005615 · doc4.xml · derivative · entry 4 Fyrwald J Erik · CIK 0001343564 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,625 Underlying: Common Stock · 47,625 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 15,875 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 15,875 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:24 UTC |
Finzel RalfEVP, Global Operations Officer
|
GrantRestricted Stock Units · Derivative | 5,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005614 · doc4.xml · derivative · entry 2 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,092 Underlying: Common Stock · 5,953 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 1,984 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 1,985 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 1,984 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 1,985 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:23 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005613 · doc4.xml · derivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,077 Underlying: Common Stock · 8,334 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 2,778 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 2,778 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:23 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
GrantRestricted Stock Units · Derivative | 7,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005612 · doc4.xml · derivative · entry 2 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,665 Underlying: Common Stock · 7,144 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 2,381 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 2,382 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 2,381 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 2,382 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:23 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
GrantRestricted Stock Units · Derivative | 5,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005611 · doc4.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,769 Underlying: Common Stock · 5,209 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 1,736 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 1,737 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 1,736 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 1,737 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:22 UTC |
Herriott SimonPres. Health & Bioscience
|
GrantRestricted Stock Units · Derivative | 8,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005610 · doc4.xml · derivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,341 Underlying: Common Stock · 8,930 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 2,976 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 2,978 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 2,976 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 2,978 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F3 · balance_after: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:22 UTC |
Arora YuvrajPresident, Nourish
|
GrantRestricted Stock Units · Derivative | 10,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005609 · doc4.xml · derivative · entry 1 Arora Yuvraj · CIK 0001982045 · President, Nourish 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,563 Underlying: Common Stock · 10,716 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 3,572 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 3,572 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:22 UTC | GrantRestricted Stock Units · Derivative | 11,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005608 · doc4.xml · derivative · entry 2 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,447 Underlying: Common Stock · 11,906 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 3,968 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 3,970 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 3,968 shares of Common Stock on each of May 1, 2025, May 1, 2026 and 3,970 shares of Common Stock on May 1, 2027, subject to continued employment with IFF. Read SEC document |
|
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · derivative · entry 6 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 346 shares Expires 2024-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · derivative · entry 5 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,743 Underlying: Common Stock · 622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on April 5, 2024. F4 · derivative.expiration_date: The RSUs vested on April 5, 2024. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 225 | $83.34 | $18,751.50 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · nonDerivative · entry 4 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,815 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 125 | $83.34 | $10,417.50 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · nonDerivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,040 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:28 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005018 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 518 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · derivative · entry 6 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 518 shares Expires 2024-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · derivative · entry 5 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,560 Underlying: Common Stock · 622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F4 · derivative.exercise_date: The RSUs vested on April 5, 2024. F4 · derivative.expiration_date: The RSUs vested on April 5, 2024. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 193 | $83.34 | $16,084.62 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · nonDerivative · entry 4 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,808 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 161 | $83.34 | $13,417.74 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · nonDerivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,001 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 518 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:25 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005016 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionRestricted Stock Units · Derivative | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · derivative · entry 6 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 346 shares Expires 2024-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionRestricted Stock Units · Derivative | 1,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · derivative · entry 5 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,411 Underlying: Common Stock · 1,244 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F4 · derivative.exercise_date: The RSUs vested on April 5, 2024. F4 · derivative.expiration_date: The RSUs vested on April 5, 2024. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Tax withholdingCommon Stock | 386 | $83.34 | $32,169.24 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · nonDerivative · entry 4 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,001.571 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Tax withholdingCommon Stock | 108 | $83.34 | $9,000.72 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · nonDerivative · entry 3 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,387.571 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,495.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 21:26 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionCommon Stock | 1,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005017 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 5, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:24 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionRestricted Stock Units · Derivative | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004872 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,655 Underlying: Common Stock · 1,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on April 1, 2024. F4 · derivative.expiration_date: The RSUs vested on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:24 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Tax withholdingCommon Stock | 461 | $86.37 | $39,816.57 |
DisclosureSEC source: 0001225208-24-004872 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,905.571 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:24 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Exercise / conversionCommon Stock | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004872 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,366.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:18 UTC |
Fyrwald J ErikDirector · CEO
|
GrantRestricted Stock Units · Derivative | 56,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003475 · doc4.xml · derivative · entry 4 Fyrwald J Erik · CIK 0001343564 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2027-03-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:06 UTC |
Clyburn FrankChief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003735 · doc4.xml · derivative · entry 3 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,682 Underlying: Common Stock · 1,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on March 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on March 1, 2024. F4 · derivative.expiration_date: The RSUs vested on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:06 UTC |
Clyburn FrankChief Executive Officer
|
Tax withholdingCommon Stock | 323 | $75.88 | $24,509.24 |
DisclosureSEC source: 0001225208-24-003735 · doc4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,847 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:06 UTC |
Clyburn FrankChief Executive Officer
|
Exercise / conversionCommon Stock | 1,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003735 · doc4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on March 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:05 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
Tax withholdingCommon Stock | 104 | $75.88 | $7,891.52 |
DisclosureSEC source: 0001225208-24-003734 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,877.571 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:05 UTC |
Herriott SimonPres. Health & Biosci. & Scent
|
GrantCommon Stock | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003734 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · Pres. Health & Biosci. & Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,981.571 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2021-2023 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2021, the first stock trading day of the LTIP cycle. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:05 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 81 | $75.88 | $6,146.28 |
DisclosureSEC source: 0001225208-24-003733 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,197 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:05 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
GrantCommon Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003733 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,278 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2021-2023 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2021, the first stock trading day of the LTIP cycle. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:04 UTC | Tax withholdingCommon Stock | 46 | $75.88 | $3,490.48 |
DisclosureSEC source: 0001225208-24-003732 · doc4.xml · nonDerivative · entry 2 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,646 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
|
| March 01, 2024 Filed Mar 6, 2024 00:04 UTC | GrantCommon Stock | 99 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003732 · doc4.xml · nonDerivative · entry 1 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,692 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2021-2023 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to September 27, 2021, the first stock trading day of the LTIP cycle. Read SEC document |
|
| March 01, 2024 Filed Mar 6, 2024 00:04 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 48 | $75.88 | $3,642.24 |
DisclosureSEC source: 0001225208-24-003731 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,022 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:04 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
GrantCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003731 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,070 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2021-2023 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2021, the first stock trading day of the LTIP cycle. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:06 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000374 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,182 Underlying: Common Stock · 1,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on January 3, 2024. F4 · derivative.expiration_date: The RSUs vested on January 3, 2024. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:06 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 478 | $79.99 | $38,235.22 |
DisclosureSEC source: 0001225208-24-000374 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,940 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:06 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000374 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:52 UTC |
Yildiz BerilCAO, SVP & Controller
|
GrantCommon Stock | 52.201 | $79.62 | $4,156.24 |
DisclosureSEC source: 0001225208-23-011288 · doc4.xml · nonDerivative · entry 1 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 740.201 F1 · shares: Reflects issuer's Common Stock received upon deferral of a portion of the reporting person's annual compensation into the issuer's stock fund. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Finzel RalfEVP, Global Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010660 · doc4.xml · derivative · entry 3 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,139 Underlying: Common Stock · 5,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on December 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on December 1, 2023. F4 · derivative.expiration_date: The RSUs vested on December 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Finzel RalfEVP, Global Operations Officer
|
Tax withholdingCommon Stock | 1,943 | $76.78 | $149,183.54 |
DisclosureSEC source: 0001225208-23-010660 · doc4.xml · nonDerivative · entry 2 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,444 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:17 UTC |
Finzel RalfEVP, Global Operations Officer
|
Exercise / conversionCommon Stock | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010660 · doc4.xml · nonDerivative · entry 1 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on December 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:12 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009921 · doc4.xml · derivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,365 Underlying: Common Stock · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on November 1, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on November 1, 2023. F4 · derivative.expiration_date: The RSUs vested on November 1, 2023. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:12 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 376 | $68.06 | $25,590.56 |
DisclosureSEC source: 0001225208-23-009921 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,083 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.